ETHOS Genetics - Digital Magazine

ETHOS Genetics - Digital Magazine

Share this post

ETHOS Genetics - Digital Magazine
ETHOS Genetics - Digital Magazine
The Future of Seeds

The Future of Seeds

HOW ACCESS TO RETAIL WILL AFFECT THE SEED GAME

Sep 21, 2022
∙ Paid
1

Share this post

ETHOS Genetics - Digital Magazine
ETHOS Genetics - Digital Magazine
The Future of Seeds
Share

By Colin Gordon & Ben Owens

The landscape of seeds as we know it is going to change so dramatically it will be almost unrecognizable.

In January 2022, Terrence L. Boos, Ph.D., Chief of the DEA’s Drug & Chemical Evaluation Section penned a letter clarifying that all parts of the cannabis plant are legal so long as they contain less than 0.3% THC.1 

‘The term “hemp” is “the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9-tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis.”’

The DEA letter went on to state that, in addition to seeds, “tissue culture and any other genetic material that has a delta-9-tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis meets the definition of “hemp” and thus is not controlled under the CSA.”1

In short, all parts of the cannabis plant that contain less than 0.3% THC are not considered controlled substances, and are unregulated (“legal”).

Since this clarification, some of the nation’s biggest distributors of consumer goods are starting to look at the different potentials of offering cannabis seeds as a product. But what’s most important is not what these distributors are trying to do—it’s the fact that there’s a new retail movement emerging.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 ETHOS Genetics
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share